This article, published by Consulting.ca, discusses results from Buck’s 2019 Canadian Health Trend Survey, which showed that insurance providers’ pharmaceutical trend factor increases were significantly higher than increases in actual drug costs.
Related insights
Update: U.S. pension risk transfer market insights – December
Download this Thought leadership as a printable PDF Market snapshot for Q3 2020 The...
Read moreArticle: A leap into the unknown: Workforce lessons from the pandemic
In this article published by BenefitsPRO, Buck Managing Director Dean Aloise looks at changes, trends and lessons learned...
Read moreUpdate: Innovation in testing and treatment in vaccines for the workplace – Issue #9
Download this Health Update as a printable PDF Vaccine update Multiple vaccines are in...
Read more